These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 15123230

  • 1. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R.
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [Abstract] [Full Text] [Related]

  • 2. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
    Jonkers RE, Bantje TA, Aalbers R.
    Respir Res; 2006 Dec 04; 7(1):141. PubMed ID: 17144916
    [Abstract] [Full Text] [Related]

  • 3. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
    Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J.
    Pulm Pharmacol Ther; 2001 Dec 04; 14(1):29-34. PubMed ID: 11162416
    [Abstract] [Full Text] [Related]

  • 4. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C, Naya I, Ekelund J.
    Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479
    [Abstract] [Full Text] [Related]

  • 5. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004 Jul 01; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 6. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep 01; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 7. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul 01; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 8. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar 01; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 9. Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction.
    van der Woude HJ, Postma DS, Politiek MJ, Winter TH, Aalbers R.
    Respir Med; 2004 Sep 01; 98(9):816-20. PubMed ID: 15338791
    [Abstract] [Full Text] [Related]

  • 10. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
    Tarsin WY, Pearson SB, Assi KH, Chrystyn H.
    Int J Pharm; 2006 Jun 19; 316(1-2):131-7. PubMed ID: 16584855
    [Abstract] [Full Text] [Related]

  • 11. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 19; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 12. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
    Aalbers R, Boorsma M, van der Woude HJ, Jonkers RE.
    Respir Res; 2010 May 28; 11(1):66. PubMed ID: 20509942
    [Abstract] [Full Text] [Related]

  • 13. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A.
    Respir Med; 2007 Dec 28; 101(12):2437-46. PubMed ID: 17905575
    [Abstract] [Full Text] [Related]

  • 14. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC, Martin P, Mezzanotte WS.
    J Asthma; 2008 May 28; 45(4):265-72. PubMed ID: 18446589
    [Abstract] [Full Text] [Related]

  • 15. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T.
    Ther Adv Respir Dis; 2009 Aug 28; 3(4):1-11. PubMed ID: 19734176
    [Abstract] [Full Text] [Related]

  • 16. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
    J Allergy Clin Immunol; 2008 Jun 28; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [Abstract] [Full Text] [Related]

  • 17. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
    Lötvall J, Langley S, Woodcock A.
    Respir Res; 2006 Aug 18; 7(1):110. PubMed ID: 16919161
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep 18; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 19. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
    Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
    Br J Clin Pharmacol; 2003 Nov 18; 56(5):494-500. PubMed ID: 14651722
    [Abstract] [Full Text] [Related]

  • 20. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.
    Dalby C, Polanowski T, Larsson T, Borgström L, Edsbäcker S, Harrison TW.
    Respir Res; 2009 Oct 31; 10(1):104. PubMed ID: 19878590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.